June 2020 DMID Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

NB: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Fiscal Year (FY) 2022 Concepts

FY 2021 Concepts

FY 2020 Concept

A Multidisciplinary Approach To Study Vaccine-Elicited Immunity and Efficacy Against Malaria

For the published request for applications, see the October 7, 2020 Guide announcement, A Multidisciplinary Approach To Study Vaccine-Elicited Immunity and Efficacy Against Malaria (U01 Clinical Trial Not Allowed).

Tropical Medicine Research Centers

For the published requests for applications, refer to the March 5, 2021 Guide notices: 

Coccidioidomycosis Collaborative Research Centers

For the published request for applications, see the October 8, 2020 Guide announcement, Coccidioidomycosis Collaborative Research Centers (U19 Clinical Trial Not Allowed).

Understanding the Role of the M. Tuberculosis Granuloma in Tuberculosis (TB) Disease and Treatment Outcomes

For the published request for applications, see the September 29, 2020 Guide announcement, Understanding the Role of the M. Tuberculosis Granuloma in Tuberculosis (TB) Disease and Treatment Outcomes (R01 Clinical Trial Not Allowed).

Tuberculosis Research Advancement Centers (TRACs)

For the published request for applications, see the January 7, 2021 Guide announcement, Tuberculosis Research Advancement Centers (P30, Clinical Trials Not Allowed).

Understanding Evolutionary Dynamics of Influenza To Inform and Improve Vaccine Strain Selection

For the published request for applications, see the September 25, 2020 Guide announcement, Understanding Evolutionary Dynamics of Influenza to Inform and Improve Vaccine Strain Selection (R01, Clinical Trial Not Allowed).

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)

For the published program announcements with special receipt, referral, or review considerations, see the April 30, 2020 Guide announcements:

Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)

For the published notice of special interest, see the May 19, 2020 Guide notice, Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19).

Notice of Special Interest (NOSI) Regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)

For the published notice of special interest, see the July 6, 2020 Guide notice, Notice of Special Interest (NOSI)—Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19).

 

Content last reviewed on